Chris Lowe is the founder of Nusano. Nusano has raised $41M in total funding. Latest round: Seed. Backed by Wasatch Group. Based in Valencia, California, US.
Chris Lowe is the CEO of Nusano, a company focused on transforming the production of medical-grade radioisotopes to advance cancer treatment and healthcare. Nusano, formerly Alpha Source Inc./Alpha Isotopes, secured a $41 million seed funding round in 2018. Lowe also serves on the BioUtah Board.
Full founder directory · Investor directory · Company funding database · Fundraising library